Status:
UNKNOWN
Ketoconazole Gel Versus Terconazole Cream for Vaginal Candidiasis
Lead Sponsor:
Assiut University
Conditions:
Vaginal Candidiasis
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
Vaginal Candidiasis is an infection caused by a yeast normally lives inside the body . Sometimes Candida can multiply and cause an infection if the environment inside the vagina changes in a way that ...
Detailed Description
terconazole- Terconazole, an azole antifungal agent, inhibits fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylase enzyme. This enzyme functions to convert lanosterol to ergosterol. The ac...
Eligibility Criteria
Inclusion
- The selected patients had - vaginal candidiasis ,diagnosed by history of pruritus in addition to the characteristic discharge of vaginal candidiasis by vaginal examination
Exclusion
- Women on other line of treatment as antimicrobial treatment either topical or systemic drugs within one month prior to the first clinical examination
- Known hypersensitivity for ketoconazole
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2019
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT03473418
Start Date
April 1 2018
End Date
April 1 2019
Last Update
March 22 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.